Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

2C-EF

From Wikipedia, the free encyclopedia

Pharmaceutical compound
2C-EF
Clinical data
Other names4-(2-Fluoroethyl)-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-(2-fluoroethyl)phenethylamine
Routes of
administration
Oral[1]
Drug classSerotonergic psychedelic;Hallucinogen
ATC code
  • None
Pharmacokinetic data
MetabolismDeamination (MAOTooltip monoamine oxidase),demethylation,hydroxylation,acetylation,glucuronidation[2]
Duration of action12 hours[1]
Identifiers
  • 2-[4-(2-fluoroethyl)-2,5-dimethoxyphenyl]ethan-1-amine
CAS Number
PubChemCID
ChemSpider
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC12H18FNO2
Molar mass227.279 g·mol−1
3D model (JSmol)
  • COC1=CC(=C(C=C1CCN)OC)CCF
  • InChI=1S/C12H18FNO2/c1-15-11-8-10(4-6-14)12(16-2)7-9(11)3-5-13/h7-8H,3-6,14H2,1-2H3
  • Key:KXPMRPNOYIOXFY-UHFFFAOYSA-N

2C-EF, also known as4-(2-fluoroethyl)-2,5-dimethoxyphenethylamine, is apsychedelic drug of thephenethylamine and2C families.[3][4][1] It is the 2Canalogue of theDOx psychedelicDOEF.[3][4] The drug is takenorally.[3][1] 2C-EF was first described in the literature byAlexander Shulgin in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved.[4]

Use and effects

[edit]

While 2C-EF was briefly mentioned byAlexander Shulgin in his bookPiHKAL (Phenethylamines I Have Known and Loved), its properties and effects were not described.[4] Subsequently, in his bookThe Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds, Shulgin listed 2C-EF's dose range as 6 to 12 mgorally and itsduration as 12 hours.[1][3] This information was cited via personal communication with M. Mueller in 2006.[3]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

2C-EF ismetabolized bymonoamine oxidase (MAO)enzymes, includingmonoamine oxidase A (MAO-A) and/ormonoamine oxidase B (MAO-B).[2]Monoamine oxidase inhibitors (MAOIs) such asphenelzine,tranylcypromine,moclobemide, andselegiline may potentiate the effects of 2C-EF.[2][5] This may result inoverdose and serioustoxicity.[2][5]

Pharmacology

[edit]

Pharmacodynamics

[edit]

2C-EF is aserotonergic psychedelic and hence presumably acts as aserotonin5-HT2A receptoragonist.[1]

Pharmacokinetics

[edit]

Themetabolism of 2C-EF has been studiedin vitro.[2] It undergoesdemethylation at position 2 or 5,hydroxylation, anddeamination, as well asacetylation andglucuronidation.[2] Oxidative deamination, mediated mainly bymonoamine oxidase (MAO)enzymes, is the main route of metabolism for 2C-EF.[2]

Chemistry

[edit]

Analogues

[edit]

Analogues of 2C-EF include2C-E,2C-T-21,2C-TFM,2C-TFE,DOEF, and2C-EF-FLY, among others.[4][6][7][8]

History

[edit]

2C-EF was originally named byAlexander Shulgin in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[4] However, he only speculated about it and never actuallysynthesized or tested it himself.[4] Subsequently, 2C-EF was synthesized and tested by others such asDaniel Trachsel.[9][6]: 770 

See also

[edit]

References

[edit]
  1. ^abcdefHalberstadt AL, Chatha M, Stratford A, Grill M, Brandt SD (January 2019)."Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran ("FLY") and benzodifuran ("DragonFLY") analogs".Neuropharmacology.144:368–376.doi:10.1016/j.neuropharm.2018.10.037.PMC 6863604.PMID 30385253.According to Shulgin and Shulgin (1991), 2C-E is active at doses of 10–25 mg. 4-(2-Fluoroethyl)-2,5-dimethoxyphenethylamine (2C-EF) also reportedly acts as a hallucinogen and is orally active in humans at doses of 6–12 mg with a duration of 12 hours (Shulgin et al. 2011), although information about the extent of recreational use of this substance appears to be lacking.
  2. ^abcdefgArbouche N, Gheddar L, Ameline A, Raul JS, Kintz P (2025)."Metabolic profiling of 2C-EF in human liver microsomes: Identification of major metabolites and biotransformation pathways".Toxicologie Analytique et Clinique.doi:10.1016/j.toxac.2025.08.005.
  3. ^abcdeShulgin A, Manning T, Daley P (2011).The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley:Transform Press.ISBN 978-0-9630096-3-0.2C-EF [...] (7,8) [...] (7) Not in the published scientific literature. (8) Orally active in humans at 6-10 mg; duration 12 hours (Mueller, 2006).
  4. ^abcdefgShulgin A,Shulgin A (September 1991).PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press.ISBN 0-9630096-0-5.OCLC 25627628."DOEF".And I'll bet you dollars to doughnuts, that if one were to make the two-carbon analog 2,5-dimethoxy-4-(2-fluoroethyl)phenethylamine, it would be every bit as much a treasure and ally as is 2C-B or 2C-I. In fact, I am sure enough about this prediction that I am willing to name the stuff 2C-EF. It will be easily made from 2C-B by the same reaction scheme that was used above for DOEF. And I will even guess that its activity level will be in the 20–30 milligram area.
  5. ^abHalman A, Kong G, Sarris J, Perkins D (January 2024)."Drug-drug interactions involving classic psychedelics: A systematic review".Journal of Psychopharmacology.38 (1):3–18.doi:10.1177/02698811231211219.PMC 10851641.PMID 37982394.
  6. ^abTrachsel D, Lehmann D, Enzensperger C (2013).Phenethylamine: Von der Struktur zur Funktion. Nachtschatten Verlag AG.ISBN 978-3-03788-700-4.
  7. ^Wagmann L, Hempel N, Richter LH, Brandt SD, Stratford A, Meyer MR (October 2019). "Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings".Drug Testing and Analysis.11 (10):1507–1521.doi:10.1002/dta.2675.PMID 31299701.
  8. ^Santos-Toscano R, Guirguis A, Davidson C (March 2020)."How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe".British Journal of Clinical Pharmacology.86 (3):452–481.doi:10.1111/bcp.14224.PMC 7080617.PMID 32045495.
  9. ^Clare BW (September 1998). "The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens".Journal of Medicinal Chemistry.41 (20):3845–3856.doi:10.1021/jm980144c.PMID 9748359.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=2C-EF&oldid=1323707329"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp